Last year, Lotus Health experienced a rebirth. The reorganization was successful, and the business continued to improve. 202 1, Lotus Health will soon complete the overall relocation, and realize another transformation stage from going out of the city to entering the garden.
Lotus set sail again, bidding farewell to years of continuous operating losses.
According to the annual report, in 2020, Lotus Health sold monosodium glutamate 1 17600 tons, chicken essence 24800 tons and flour1/8200 tons, among which the volume and price of the core product monosodium glutamate rose by nearly 1000 tons, ending the continuous decline in the past decade.
During the reporting period, the company achieved sales revenue of 654.38+655.5 million yuan, which was reduced by 2.8 1% due to the COVID-19 epidemic. The net profit attributable to shareholders of listed companies was 742,865,438+million yuan, a year-on-year increase of 7.30%; After deducting non-recurring profit and loss factors, the company bid farewell to the situation of continuous operating losses for many years and turned losses into profits; Foreign exchange earned by export was 26.69 million US dollars, an increase of 6.5438 US dollars+270,000 US dollars.
Lotus Health said that in 2020, faced with the impact of the novel coronavirus epidemic, the company continued to deepen reform, strengthen enterprise management, and actively took effective measures to basically complete the tasks assigned by the board of directors in 2020. The company's stock took off the *ST hat and its production and operation returned to the track of healthy and sustainable development.
Henan Business Daily noted that the financial data of Lotus Health in 2020 gradually returned to health after the initial recovery from a serious illness. The specific performance is as follows: the management cost is 59.49 million yuan, down 68.94% year-on-year, mainly because the number of employees has been greatly reduced after the company completed the judicial reorganization, and the company has strengthened cost control; R&D expenditure was 6.5438+0.772 million yuan, up by 654.38+0.700.39% year-on-year, which was mainly due to the increase in R&D investment after the reorganization of the company. The financial expenses were 654.38+09 million yuan, down 44.62% year-on-year, mainly due to the adjustment of financing structure and the reduction of comprehensive financing costs.
In addition, the company's product revenue and gross profit are also gradually improving. In 2020, the sales revenue of liquid condiments such as cooking wine was 3,345,900 yuan, a year-on-year increase of 159. 18%, and the gross profit margin increased by 1 17.84%. Lotus Health said that the company mainly strengthened the market development, product promotion and cost control of liquid condiments such as cooking wine.
202 1 will focus on the consumption scene of "two kitchens" for home and catering.
Since its establishment, Lotus Health has been committed to the research, development, production and sales of edible condiments, and has formed a green product structure with monosodium glutamate and chicken essence as the leading factor and a combination of condiment series, plant protein series and wheat flour series. Seasoning series mainly includes "Lotus" brand monosodium glutamate, "Lotus" brand chicken essence, "Jiupinxiang" seasoning and other products, plant protein series mainly includes gluten products, and wheat flour series mainly includes "June Spring" brand flour. Among them, monosodium glutamate is the core product of the company.
Combing the lotus health in 2020, there are many important nodes in the future development of the company. In March 2020, the company completed the reorganization procedure and successfully resolved the delisting risk and debt crisis. The reorganization funds paid off the employees' creditor's rights in full according to law, and the surplus employees were monetized, which not only safeguarded the legitimate rights and interests of employees, but also maintained the basic stability of the overall local society.
During the reporting period, the company actively promoted the non-public offering of shares, and was approved to issue no more than 465,438+03,977,65,438+086 new shares in June 2020. Lotus Health said that the steady implementation of the company's refinancing will definitely help the company to implement project construction, optimize the industrial structure, enrich product categories, enhance the company's comprehensive strength, and improve the company's sustainable operation ability and profitability.
Last year, Lotus Health accelerated the implementation of the project of leaving the city and entering the park, actively raised funds and increased investment in the construction of the new district. All the main projects of the project were completed, which laid a good foundation for the company to complete the overall relocation in the first half of 2002/KLOC-0.
Lotus Health said that the company will continue to develop and improve the existing condiment production capacity, and expand the development and marketing of condiment products including monosodium glutamate, chicken essence and compound seasoning, wheat flour products and wheat starch products. At the same time, the company will be guided by consumer demand, constantly develop new health condiments, health foods and other different categories, promote product upgrading, and establish a more perfect health food warehouse.
Regarding the development strategy of 20021,Lotus Health said that the management of the company will focus on the "two kitchens" consumption scenarios of home and catering around the company's development strategy, take the market demand as the guide, meet the "three major consumption needs" of health, nutrition and delicacy, adhere to the product policy of paying equal attention to monosodium glutamate and new products, increase the research and development and marketing of new products, and promote the transformation and upgrading of the company's strategic products.
(Editor of Henan Business Daily Shi Shang Jing Liu Mengge)